Portfolio (Quarterly)
Guide ↗
Stonepine Capital Management, LLC
· CIK 0001440771| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | VERASTEM INC | — | 2,732,079.0 | $21.1M | 15.40% | NEW | — | $7.72 | — |
| 2 | ADMA | ADMA BIOLOGICS INC | Healthcare | 740,000.0 | $13.5M | 9.85% | NEW | — | $18.24 | -55.0% |
| 3 | EOLS | EVOLUS INC | Healthcare | 1,631,588.0 | $10.9M | 7.92% | NEW | — | $6.65 | -6.6% |
| 4 | — | ZEVRA THERAPEUTICS INC | — | 569,088.0 | $5.1M | 3.72% | NEW | — | $8.96 | — |
| 5 | — | INHIBIKASE THERAPEUTICS INC | — | 2,348,147.0 | $4.8M | 3.51% | NEW | — | $2.05 | — |
| 6 | — | ABEONA THERAPEUTICS INC | — | 709,505.0 | $3.7M | 2.73% | NEW | — | $5.27 | — |
| 7 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 85,000.0 | $3.6M | 2.62% | NEW | — | $42.28 | +55.6% |
| 8 | — | INDIVIOR PLC | — | 100,000.0 | $3.6M | 2.62% | NEW | — | $35.88 | — |
| 9 | — | CORBUS PHARMACEUTICALS HLDGS | — | 389,916.0 | $3.2M | 2.32% | NEW | — | $8.14 | — |
| 10 | KZIA | KAZIA THERAPEUTICS LTD | Healthcare | 460,359.0 | $3.2M | 2.32% | NEW | — | $6.89 | +86.5% |
| 11 | XOMA | XOMA ROYALTY CORPORATION | Healthcare | 115,000.0 | $3.1M | 2.23% | NEW | — | $26.59 | +56.5% |
| 12 | VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | 353,669.0 | $2.9M | 2.15% | NEW | — | $8.31 | -26.4% |
| 13 | HELP | CYBIN INC | Healthcare | 339,902.0 | $2.8M | 2.03% | NEW | — | $8.18 | -46.1% |
| 14 | TELA | TELA BIO INC | Healthcare | 2,352,032.0 | $2.8M | 2.03% | NEW | — | $1.18 | -29.4% |
| 15 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 100,000.0 | $2.7M | 1.95% | NEW | — | $26.71 | -20.6% |
| 16 | CRSP CALL | CRISPR THERAPEUTICS AG | Healthcare | 50,000.0 | $2.6M | 1.91% | NEW | — | $52.44 | -1.6% |
| 17 | — | SURROZEN INC | — | 113,631.0 | $2.6M | 1.88% | NEW | — | $22.60 | — |
| 18 | ARE CALL | ALEXANDRIA REAL ESTATE EQ IN | Real Estate | 50,000.0 | $2.4M | 1.79% | NEW | — | $48.94 | -1.7% |
| 19 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 593,573.0 | $2.4M | 1.73% | NEW | — | $4.00 | +0.3% |
| 20 | RARE CALL | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 100,000.0 | $2.3M | 1.68% | NEW | — | $23.00 | +1.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%